TickerFacts.

AEON Biopharma, Inc. (AEON): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$17.31M
Year ended 2025-12-31
2022-12-31: -$35.89M2025-12-31: -$17.31M-$17.31M
2022-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$17.31Mn/a2026-03-30, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31-$35.89Mn/a2024-05-14, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
AEON Biopharma, Inc. (AEON)2025-12-31-$17.31Mn/a
CDT Equity Inc. (CDT)2024-12-31-$9.73Mn/a
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31-$6.99Mn/m
Quantum Cyber N.V. (QUCY)2025-12-31-$10.98Mn/m
Ernexa Therapeutics Inc. (ERNA)2025-12-31-$7.05Mn/m
Petros Pharmaceuticals, Inc. (PTPI)2024-12-31-$2.63Mn/a
Azitra, Inc. (AZTR)2025-12-31-$11.25Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.50Mn/m
International Stem Cell Corp (ISCO)2025-12-31-$35.0Kn/m

Compare AEON, CDT, SXTP, QUCY side by side · Screen every company in Pharmaceutical Preparations ↗